Prenetics is a consumer health company whose core business is IM8, a DTC premium supplement brand co-founded with David Beckham and launched in December 2024. IM8 sells all-in-one daily supplement products targeting general health performance and longevity, positioning itself as a replacement for multiple individual supplements. IM8 sells exclusively through its own website and social media channels — no retail or third-party distribution. Customers subscribe on monthly or quarterly plans, with roughly 80% of new customers opting into a subscription at purchase. IM8's two flagship products are Daily Ultimate Essentials Pro, an all-in-one daily supplement covering vitamins, minerals, adaptogens, and probiotics, and Daily Ultimate Longevity, a longevity-focused formula targeting the hallmarks of aging. These are also sold together as the Beckham Stack. Prenetics acquires customers primarily through paid digital advertising on Meta and Google, and runs over 2,000 simultaneous ad creatives generated via AI. The company also retains CircleDNA, a smaller consumer genetic testing brand that delivers personalized health reports using next-generation sequencing. Prenetics views CircleDNA as complementary to IM8 given the natural cross-sell from genetic insights into supplement recommendations. Prenetics is currently unprofitable and targets adjusted EBITDA profitability by Q4 2027, driven by operating leverage as IM8 scales internationally and expands its product portfolio.